BioCentury
ARTICLE | Company News

Metabolex, Yamanouchi deal

March 24, 2003 8:00 AM UTC

Metabolex received an undisclosed milestone from partner Yamanouchi under the companies' 2002 deal to develop therapeutics to treat Type II diabetes, insulin resistance, impaired glucose tolerance (IG...